GERM vs. FMED ETF Comparison
Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to Fidelity Disruptive Medicine ETF (FMED)
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.
Grade (RS Rating)
Last Trade
$19.16
Average Daily Volume
1,248
Number of Holdings
*
2
* may have additional holdings in another (foreign) market
FMED
Fidelity Disruptive Medicine ETF
FMED Description
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.38
Average Daily Volume
5,352
Number of Holdings
*
10
* may have additional holdings in another (foreign) market
Performance
| Period | GERM | FMED |
|---|---|---|
| 30 Days | 3.00% | 4.17% |
| 60 Days | 3.68% | 7.76% |
| 90 Days | -2.06% | 12.58% |
| 12 Months | -0.17% | 14.35% |
0 Overlapping Holdings
| Symbol | Grade | Weight in GERM | Weight in FMED | Overlap |
|---|
GERM: Top Represented Industries & Keywords
Industries:
Biotechnology
Drug Manufacturers - General
FMED: Top Represented Industries & Keywords
Compare ETFs
